Subscribe To

Price Alert Latest News Economic Calendar News

ADVB / Advanced Biomed Begins $150 Million U.S. IPO Rollout

Advanced Biomed has filed to raise $150 million in a U.S. IPO, although the final amount may vary. The Taiwan-based firm is developing various diagnostic test technologies for cancer and is focused on the Chinese market. Read More

Demo Live Account See Partner Details

Content Topics

Advanced

Biomed

Begins

150 Million

Rollout

Stock

ADVB

Posted: May 23 2023, 15:36

Author Name: Seeking Alpha

ADVB News

By Seeking Alpha
July 19, 2023

IPO Update: Advanced Biomed Finalizes $112 Million U.S. IPO Plan

Advanced Biomed has filed proposed terms for a $112 million U.S. IPO. The firm is developing a portfolio of cancer screening technologies for the Chin

By Seeking Alpha
May 23, 2023

Advanced Biomed Begins $150 Million U.S. IPO Rollout

Advanced Biomed has filed to raise $150 million in a U.S. IPO, although the final amount may vary. The Taiwan-based firm is developing various diagnos

By Proactive Investors
May 23, 2023

Advanced Biomed to raise $150M in IPO

Advanced Biomed, a Taiwan-based diagnostics developer, is planning to raise up to $150 million in an initial public offering (IPO). The company said

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.